XRTX
XORTX Therapeutics Inc

2,252
Mkt Cap
$4.25M
Volume
20,618.00
52W High
$1.79
52W Low
$0.515
PE Ratio
-1.30
XRTX Fundamentals
Price
$0.611
Prev Close
$0.6101
Open
$0.6125
50D MA
$0.6859
Beta
0.42
Avg. Volume
115,582.53
EPS (Annual)
-$1.15
P/B
1.61
Loading...
Loading...
XORTX Therapeutics, Inc. is a biopharmaceutical company. The firm engages in development and commercialization of innovative therapies. It focuses on drug therapies for rare orphan disease indications such as polycystic kidney disease, and the treatment of health consequences caused by chronic high serum uric acid or hyperuricemia, including Type 2 Diabetic Nephropathy, cardiovascular disease, and diabetes. The company was founded by Allen Davidoff on May 31, 2011 and is headquartered in Calgary, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of XORTX Therapeutics Inc?
What is the 52-week high for XORTX Therapeutics Inc?
What is the 52-week low for XORTX Therapeutics Inc?
What is XORTX Therapeutics Inc stock price today?
What was XORTX Therapeutics Inc stock price yesterday?
What is the PE ratio of XORTX Therapeutics Inc?
What is the Price-to-Book ratio of XORTX Therapeutics Inc?
What is the 50-day moving average of XORTX Therapeutics Inc?

Latest XRTX News

View
No XRTX news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.